Vanda Pharmaceuticals
VNDA
#7490
Rank
S$0.53 B
Marketcap
S$9.04
Share price
4.15%
Change (1 day)
42.58%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.21 Billion. In 2024 the company made an earning of -S$52.31 Million a decrease over its 2023 earnings that were of -S$17.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion202.76%
2024 -S$52.31 Million191.43%
2023 -S$17.95 Million-320.45%
2022 S$8.14 M-84.99%
2021 S$54.24 M54.8%
2020 S$35.04 M19.42%
2019 S$29.34 M4.93%
2018 S$27.96 M-228.6%
2017 -S$21.75 Million-8.98%
2016 -S$23.9 Million-53.79%
2015 -S$51.7 Million-30.18%
2014 -S$74.05 Million173.08%
2013 -S$27.12 Million-25.33%
2012 -S$36.32 Million163.61%
2011 -S$13.78 Million-221.15%
2010 S$11.36 M-124.53%
2009 -S$46.36 Million-29.44%
2008 -S$65.7 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$84.54 Million170.55%
2005 -S$31.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$21.12 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$28.95 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.67 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.33 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.24 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.61 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.70 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA